Claritev Total Current Assets 2019-2025 | CTEV
Claritev total current assets from 2019 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| Claritev Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $176 |
| 2023 | $194 |
| 2022 | $447 |
| 2021 | $319 |
| 2020 | $209 |
| 2019 | $116 |
| 2018 | $0 |
| Claritev Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $185 |
| 2024-12-31 | $176 |
| 2024-09-30 | $212 |
| 2024-06-30 | $192 |
| 2024-03-31 | $190 |
| 2023-12-31 | $194 |
| 2023-09-30 | $212 |
| 2023-06-30 | $209 |
| 2023-03-31 | $371 |
| 2022-12-31 | $447 |
| 2022-09-30 | $529 |
| 2022-06-30 | $469 |
| 2022-03-31 | $455 |
| 2021-12-31 | $319 |
| 2021-09-30 | $306 |
| 2021-06-30 | $281 |
| 2021-03-31 | $212 |
| 2020-12-31 | $209 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $4 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.479B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.320B | 52.93 |
| Hims & Hers Health (HIMS) | United States | $11.979B | 124.46 |
| Tempus AI (TEM) | United States | $10.204B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.547B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.305B | 67.26 |
| Privia Health (PRVA) | United States | $2.816B | 192.50 |
| Enovis (ENOV) | United States | $1.849B | 10.31 |
| Clover Health Investments (CLOV) | United States | $1.669B | 0.00 |
| Schrodinger (SDGR) | United States | $1.550B | 0.00 |
| Phreesia (PHR) | United States | $1.447B | 0.00 |
| Omnicell (OMCL) | United States | $1.351B | 23.83 |
| Azenta (AZTA) | United States | $1.283B | 59.64 |
| 10x Genomics (TXG) | United States | $1.052B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.529B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| Standard BioTools (LAB) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.356B | 789.67 |
| Outset Medical (OM) | United States | $0.327B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.283B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.097B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |